INTERNATIONAL PATENT: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "COMBINATION OF ANGUBINDIN-1 ABD CHEMOTHERAPY FOR THE TREATMENT OF CNS MALIGNANCIES"

GENEVA, May 27 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Office of Technology TransferNational Institutes of Health, 6701 Rockledge Drive, Suite 700,MSC 7788Bethesda, Maryland 20892-7788) filed a patent application (PCT/US2023/079547) for "COMBINATION OF ANGUBINDIN-1 ABD CHEMOTHERAPY FOR THE TREATMENT OF CNS MALIGNANCIES" on Nov 13, 2023. With publication no. WO/2025/106064, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JACKSON, Sadhana (817 Fordham Street...